Equities
  • Price (HKD)23.86
  • Today's Change-0.18 / -0.75%
  • Shares traded58.44k
  • 1 Year change-10.97%
  • Beta0.7771
Data delayed at least 15 minutes, as of Mar 05 2026 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai Haohai Biological Technology Co Ltd is a China-based company mainly engaged in the production and sale of biological products, medical hyaluronic acid and intraocular lenses, research and development of bioengineering and pharmaceuticals, and provision of related services. The ophthalmology business has covered cataract treatment, myopia prevention and control, refractive correction, ocular surface medication, and optometry materials such as intraocular lenses and orthokeratology lenses. Medical beauty and wound care products include hyaluronic acid dermal fillers, hyaluronic acid gel for skin and mucosal superficial tissue supplementation. Orthopedic products include orthopedic joint cavity viscoelastic supplements and others. Anti-adhesion and hemostasis products include medical chitosan (for anti-adhesion), medical sodium hyaluronate gel and collagen sponge. The Company mainly conducts its businesses in domestic and foreign markets.

  • Revenue in HKD (TTM)2.91bn
  • Net income in HKD448.18m
  • Incorporated2007
  • Employees2.16k
  • Location
    Shanghai Haohai Biological Technology Co Ltd4F, No 2 Building, Alley 139Anshun Road, Changning DistrictSHANGHAI 200336ChinaCHN
  • Phone+86 2 152293555
  • Fax+86 2 152293558
  • Websitehttps://www.3healthcare.com/
More ▼

Institutional shareholders

11.64%Per cent of shares held by top holders
HolderShares% Held
Prudence Investment Management (Hong Kong) Ltd.as of 31 Dec 20241.97m5.40%
The Vanguard Group, Inc.as of 04 Feb 20261.56m4.28%
Dimensional Fund Advisors LPas of 05 Feb 2026399.64k1.10%
Vanguard Asset Management Ltd.as of 31 Jan 202668.86k0.19%
SSgA Funds Management, Inc.as of 05 Feb 202660.98k0.17%
Asset Management One Co., Ltd.as of 25 Nov 202446.20k0.13%
Segall Bryant & Hamill LLCas of 31 Jan 202645.50k0.13%
Rongtong Fund Management Co., Ltd.as of 30 Jun 202536.50k0.10%
Vanguard Fiduciary Trust Co.as of 31 Jan 202630.44k0.08%
Andbank Wealth Management SGIIC SAUas of 30 Jun 202526.03k0.07%
More ▼
Data from 31 Dec 2024 - 25 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.